Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGM2 | P21980 | 3/20 | 0.43 |
| ▸ | TGM6 | O95932 | 1/20 | 0.43 |
| ▸ | F13A1 | P00488 | 1/20 | 0.43 |
| ▸ | TGM1 | P22735 | 1/20 | 0.43 |
| ▸ | SIRT2 | Q8IXJ6 | 8/20 | 0.42 |
| ▸ | SIRT1 | Q96EB6 | 6/20 | 0.42 |
| ▸ | SIRT3 | Q9NTG7 | 3/20 | 0.42 |
| ▸ | SIRT5 | Q9NXA8 | 2/20 | 0.41 |
| ▸ | KLK7 | P49862 | 1/20 | 0.40 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.40 |
| ▸ | CPB1 | P15086 | 1/20 | 0.40 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.40 |
| ▸ | TLR2 | O60603 | 2/20 | 0.39 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31624525 | 0.98 | TGM2 (0.42) | TGM2TGM6F13A1TGM1SIRT2 | |
| SCHEMBL31624336 | 0.87 | SIRT2 (0.41) | TGM2TGM6F13A1TGM1SIRT2 | |
| SCHEMBL31624377 | 0.86 | HDAC1 (0.42) | TGM2TGM6F13A1TGM1SIRT2 | |
| SCHEMBL31624378 | 0.86 | HDAC1 (0.42) | TGM2TGM6F13A1TGM1SIRT2 | |
| SCHEMBL31624473 | 0.85 | ITGB3 (0.46) | TGM2TGM6F13A1TGM1SIRT2 | |
| SCHEMBL31631377 | 0.83 | SIRT2 (0.44) | TGM2TGM6F13A1TGM1SIRT2 | |
| SCHEMBL31624488 | 0.82 | TLR2 (0.40) | TGM2TGM6F13A1TGM1SIRT2 | |
| SCHEMBL31624468 | 0.82 | TLR2 (0.40) | TGM2TGM6F13A1TGM1SIRT2 | |
| SCHEMBL31624411 | 0.82 | SIRT2 (0.54) | SIRT2SIRT1SIRT3KLK7KLK5 | |
| SCHEMBL31631364 | 0.82 | SIRT2 (0.54) | SIRT2SIRT1SIRT3KLK7KLK5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025128626-A1 | HYBRID PEPTIDE COMPOUNDS HAVING A MODIFIED LYSINE RESIDUE | CARMOT THERAPEUTICS, INC. (US) | 2025-06-19 | — | — | WO | disclosed |
| WO-2025128624-A2 | HYBRID PEPTIDE COMPOUNDS HAVING A SUBSTITUTED TRYPTOPHAN RESIDUE OR A TERMINAL SUBSTITUENT | CARMOT THERAPEUTICS, INC. (US) | 2025-06-19 | — | — | WO | disclosed |